Key Takeaways Zimmer Biomet's Q3 adjusted EPS rose 9.2% year over year, topping the consensus estimate.Revenues grew 9.7% to $2.00B but missed expectations due to weakness in Knees and Hips.The company reaffirmed EPS guidance but narrowed its revenue growth outlook for 2025.Zimmer Biomet Holdings, Inc. (ZBH) posted third-quarter 2025 adjusted earnings per share (EPS) of$1.90, which beat the Zacks Consensus Estimate by 1.06%. The adjusted figure rose 9.2% year over year.The quarter’s adjustments included ce ...